When topotecan (0.75 mg/ m2/ day for 5 consecutive days) and cisplatin (60 mg/ m2/ day on Day 1) were administered in 13 patients with ovarian cancer, a slight increase in AUC (12%, n=9) and Cmax (23%, n=11) was noted on day 5.